Physician
The Wright Center Medical Group
The Wright Center Medical Group was paid $106.10M by Medicaid between Jun 2019 and Dec 2024, across 250 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 94% of everything it billed.
33Billing provider infoTHE WRIGHT CENTER MEDICAL GROUP
SCRANTON, PA 18505
SCRANTON, PA 18505
33aNPI1649836941assigned 05/13/2019
33bProvider typeRheumatology Physician
28Total paid$106.10M
24GClaims1,249,699
24DCodes billed250
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other Rheumatology Physician providers in Pennsylvania
Rank by total paid#1 of 77
Median peer was paid$7K
This provider vs. median15,964×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 112,707 | $6.54M | |
| 2020 | 281,126 | $15.48M | |
| 2021 | 301,923 | $20.43M | |
| 2022 | 162,582 | $20.84M | |
| 2023 | 179,017 | $21.14M | |
| 2024incomplete | 212,344 | $21.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 94% | 303,220 | 220,083 | $100.11M |
| G9012 | Other specified case management service not elsewhere classified | 4.5% | 17,472 | 17,242 | $4.72M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | <1% | 10,913 | 3,327 | $191K |
| 99223 | Prolong inpt eval add15 m | <1% | 3,374 | 3,162 | $164K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 100,953 | 87,578 | $153K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 6,362 | 6,120 | $87K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 39,447 | 36,008 | $71K |
| 0012A | <1% | 2,121 | 2,102 | $65K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 7,200 | 1,908 | $59K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 4,209 | 3,896 | $50K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 4,902 | 4,707 | $41K |
| 0011A | <1% | 2,389 | 2,365 | $40K |
238 more codes
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 695 | $35K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,591 | $25K |
| 80305 | <1% | 23,484 | $24K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,475 | $21K |
| 0002A | <1% | 510 | $20K | |
| 0064A | <1% | 1,240 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,168 | $17K |
| 99441 | <1% | 775 | $16K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,579 | $14K |
| 0001A | <1% | 554 | $14K | |
| 99385 | <1% | 1,976 | $11K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,169 | $8K |
| 0071A | <1% | 213 | $8K | |
| G0467 | Community health center visit, returning patient | <1% | 20,565 | $8K |
| 0072A | <1% | 186 | $8K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,941 | $7K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,017 | $7K |
| 0134A | <1% | 576 | $6K | |
| 99442 | <1% | 670 | $6K | |
| 90734 | <1% | 2,361 | $5K | |
| 99386 | <1% | 888 | $5K | |
| 94760 | <1% | 3,466 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13,061 | $4K |
| 82947 | <1% | 10,701 | $4K | |
| 0003A | <1% | 89 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,950 | $2K |
| 90670 | <1% | 2,895 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 13,472 | $2K |
| 0013A | <1% | 96 | $2K | |
| 91322 | <1% | 214 | $2K | |
| 92552 | <1% | 9,953 | $2K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 3,690 | $2K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,118 | $2K |
| 3046F | <1% | 1,606 | $2K | |
| 3044F | <1% | 2,805 | $2K | |
| 90461 | <1% | 7,295 | $1K | |
| 81025 | <1% | 6,361 | $1K | |
| 90716 | <1% | 418 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,294 | $1K |
| 90651 | <1% | 2,711 | $1K | |
| 36416 | <1% | 8,875 | $1K | |
| 99383 | <1% | 519 | $983.65 | |
| 90633 | <1% | 2,313 | $973.28 | |
| 2026F | <1% | 1,114 | $850.00 | |
| G0468 | Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv | <1% | 1,522 | $838.19 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,338 | $783.08 |
| 2022F | <1% | 998 | $758.77 | |
| 90715 | <1% | 2,724 | $745.84 | |
| 90686 | <1% | 6,592 | $745.27 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 145 | $733.12 |
| 90710 | <1% | 649 | $715.70 | |
| 96160 | <1% | 4,587 | $714.49 | |
| 99173 | <1% | 8,119 | $713.82 | |
| 90707 | <1% | 441 | $710.67 | |
| 99384 | <1% | 378 | $694.94 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,850 | $694.92 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 773 | $651.69 |
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 34,709 | $642.79 |
| 99496 | <1% | 543 | $636.19 | |
| 83655 | <1% | 590 | $636.19 | |
| 0124A | <1% | 99 | $576.00 | |
| 90723 | <1% | 1,085 | $506.06 | |
| 90680 | <1% | 1,324 | $472.80 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,347 | $432.76 |
| 90696 | <1% | 391 | $397.58 | |
| G0466 | Community health center visit, new patient | <1% | 135 | $366.56 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 466 | $357.35 |
| G2089 | Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0% | <1% | 446 | $347.46 |
| 99051 | <1% | 9,007 | $341.18 | |
| 90698 | <1% | 933 | $314.04 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | <1% | 3,053 | $288.73 |
| 96127 | <1% | 11,827 | $263.36 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 7,435 | $235.64 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,053 | $199.97 |
| 3051F | <1% | 183 | $130.00 | |
| 91320 | <1% | 147 | $95.09 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 1,280 | $83.98 |
| 3052F | <1% | 518 | $70.00 | |
| 90648 | <1% | 1,845 | $68.22 | |
| 99220 | <1% | 205 | $57.98 | |
| 90480 | <1% | 446 | $40.00 | |
| 90674 | <1% | 138 | $28.26 | |
| 90744 | <1% | 701 | $26.90 | |
| 90756 | <1% | 116 | $20.39 | |
| 3078F | <1% | 17,560 | $20.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 1,566 | $12.25 |
| 3074F | <1% | 19,815 | $10.00 | |
| 3077F | <1% | 4,208 | $10.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,858 | $8.25 |
| 81002 | <1% | 996 | $6.53 | |
| 86580 | 0% | 809 | $0.00 | |
| 93000 | 0% | 1,789 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 9,784 | $0.00 |
| D0272 | Bitewings - two radiographic images | 0% | 212 | $0.00 |
| 99406 | 0% | 1,393 | $0.00 | |
| 3079F | 0% | 8,620 | $0.00 | |
| 1006F | 0% | 53 | $0.00 | |
| 91306 | 0% | 962 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 16,804 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 5,857 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 6,329 | $0.00 |
| G8952 | Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given | 0% | 1,237 | $0.00 |
| 96161 | 0% | 661 | $0.00 | |
| 85013 | 0% | 682 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 15,335 | $0.00 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | 0% | 932 | $0.00 |
| G8430 | Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) | 0% | 3,396 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 16,410 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 5,783 | $0.00 |
| D0120 | Dental checkup, returning patient | 0% | 2,455 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 19,420 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 213 | $0.00 |
| 85018 | 0% | 1,271 | $0.00 | |
| 90660 | 0% | 15 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 17,462 | $0.00 |
| 3080F | 0% | 2,588 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 2,180 | $0.00 |
| 90620 | 0% | 463 | $0.00 | |
| D1206 | Topical application of fluoride varnish | 0% | 1,678 | $0.00 |
| 1036F | 0% | 17,338 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 245 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 2,578 | $0.00 |
| 91301 | 0% | 3,911 | $0.00 | |
| 3075F | 0% | 4,849 | $0.00 | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | 0% | 302 | $0.00 |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 3,496 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 1,091 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 29 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 1,010 | $0.00 |
| 90677 | 0% | 1,008 | $0.00 | |
| D7140 | Extraction, erupted tooth or exposed root | 0% | 1,791 | $0.00 |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 41 | $0.00 |
| G9908 | Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 1,450 | $0.00 |
| D0601 | 0% | 162 | $0.00 | |
| D2331 | 0% | 204 | $0.00 | |
| G9907 | Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason) | 0% | 914 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 4,023 | $0.00 |
| D5899 | 0% | 352 | $0.00 | |
| G8542 | Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required | 0% | 175 | $0.00 |
| 3017F | 0% | 10,109 | $0.00 | |
| 0240U | 0% | 257 | $0.00 | |
| D2330 | 0% | 369 | $0.00 | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | 0% | 634 | $0.00 |
| D0603 | 0% | 147 | $0.00 | |
| 99495 | 0% | 144 | $0.00 | |
| 99217 | 0% | 40 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 136 | $0.00 |
| D0140 | Limited oral evaluation - problem focused | 0% | 347 | $0.00 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 0% | 999 | $0.00 |
| 90732 | 0% | 85 | $0.00 | |
| D1330 | 0% | 237 | $0.00 | |
| 91307 | 0% | 349 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 54 | $0.00 |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 10,288 | $0.00 |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | 0% | 42 | $0.00 |
| 3352F | 0% | 1,749 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 160 | $0.00 |
| 94761 | 0% | 26 | $0.00 | |
| 87807 | 0% | 24 | $0.00 | |
| Q0222 | Injection, bebtelovimab, 175 mg | 0% | 175 | $0.00 |
| D2335 | 0% | 100 | $0.00 | |
| 99407 | 0% | 30 | $0.00 | |
| 90656 | 0% | 627 | $0.00 | |
| 3353F | 0% | 13 | $0.00 | |
| 90688 | 0% | 34 | $0.00 | |
| D0602 | 0% | 104 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 15 | $0.00 |
| 99443 | 0% | 28 | $0.00 | |
| 99381 | 0% | 14 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 13 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 3,967 | $0.00 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 2,320 | $0.00 |
| G9920 | Screening performed and negative | 0% | 10,093 | $0.00 |
| D0330 | Panoramic radiographic image | 0% | 1,960 | $0.00 |
| D0190 | 0% | 240 | $0.00 | |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 0% | 3,245 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 913 | $0.00 |
| 4004F | 0% | 26,373 | $0.00 | |
| 99188 | 0% | 350 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 1,231 | $0.00 |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 0% | 713 | $0.00 |
| D1110 | Prophylaxis - adult | 0% | 4,104 | $0.00 |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 7,390 | $0.00 |
| D1120 | Dental cleaning, child | 0% | 967 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 6,478 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 38,409 | $0.00 |
| G9904 | Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason) | 0% | 774 | $0.00 |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 4,493 | $0.00 |
| G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible | 0% | 1,140 | $0.00 |
| G8785 | Blood pressure reading not documented, reason not given | 0% | 1,043 | $0.00 |
| G2104 | Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed | 0% | 688 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 14,336 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 3,555 | $0.00 |
| D9110 | 0% | 802 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 1,580 | $0.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 91 | $0.00 |
| 90662 | 0% | 223 | $0.00 | |
| 3015F | 0% | 406 | $0.00 | |
| 91300 | 0% | 1,338 | $0.00 | |
| D0274 | Bitewings - four radiographic images | 0% | 2,935 | $0.00 |
| G9909 | Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason) | 0% | 917 | $0.00 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 146 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 0% | 4,384 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 1,207 | $0.00 |
| 91313 | 0% | 415 | $0.00 | |
| 90380 | 0% | 13 | $0.00 | |
| 90681 | 0% | 41 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 15,792 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 3,908 | $0.00 |
| G2102 | Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed | 0% | 1,008 | $0.00 |
| G9905 | Patient not screened for tobacco use | 0% | 5,250 | $0.00 |
| 80061 | Lipid panel | 0% | 105 | $0.00 |
| G8543 | Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented within two days of assessment, reason not given | 0% | 570 | $0.00 |
| 90700 | 0% | 578 | $0.00 | |
| G8540 | Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter | 0% | 168 | $0.00 |
| 90750 | 0% | 105 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 3,244 | $0.00 |
| 99490 | Ccm add 20min | 0% | 171 | $0.00 |
| D0220 | Intraoral - periapical first radiographic image | 0% | 1,633 | $0.00 |
| 87631 | 0% | 16 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 21 | $0.00 |
| 90746 | 0% | 15 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 327 | $0.00 |
| 91312 | 0% | 69 | $0.00 | |
| S9470 | Nutritional counseling, dietitian visit | 0% | 46 | $0.00 |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 0% | 68 | $0.00 |
| 99382 | 0% | 59 | $0.00 | |
| 99177 | 0% | 104 | $0.00 | |
| 90713 | 0% | 109 | $0.00 | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 0% | 169 | $0.00 |
| D2332 | 0% | 125 | $0.00 | |
| 90682 | 0% | 61 | $0.00 | |
| 99491 | Ccm add 20min | 0% | 50 | $0.00 |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 0% | 74 | $0.00 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 38 | $0.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 12 | $0.00 |
| 90621 | 0% | 14 | $0.00 | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYASTREMSKI, SANDRA (SVP, CFO)